Lung Cancer Clinical Trial

Phase II Study of AZD9291 (Osimertinib) in Advanced Non-Small Cell Lung Cancer Patients with Exon 20 Insertion Mutations in EGFR


Physician and Research Staff Educational Material

This material is intended for promotional use among health care professionals and is NOT intended for use as patient educational material.

Information and Assistance from the National Cancer Institute

    • Locations and other information
    • Trained information specialists at the NCI are available to answer cancer-related questions from patients, family members or friends, health care providers, and researchers. Visit the NCI’s Cancer Information Service webpage for contact instructions, including telephone, live chat, email, and mail. ID: NCT03191149

Return to Home Page | Review Other Active Trials